Avanos Medical, Inc. (NYSE:AVNS) Short Interest Update

Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) was the recipient of a significant drop in short interest in January. As of January 15th, there was short interest totalling 681,400 shares, a drop of 6.4% from the December 31st total of 727,700 shares. Based on an average daily trading volume, of 349,300 shares, the short-interest ratio is currently 2.0 days. Currently, 1.5% of the shares of the stock are short sold.

Institutional Trading of Avanos Medical

A number of institutional investors have recently modified their holdings of the business. Tributary Capital Management LLC increased its holdings in Avanos Medical by 38.1% during the 4th quarter. Tributary Capital Management LLC now owns 893,008 shares of the company's stock worth $14,217,000 after acquiring an additional 246,379 shares during the period. Empowered Funds LLC grew its holdings in shares of Avanos Medical by 141.3% during the 4th quarter. Empowered Funds LLC now owns 153,834 shares of the company's stock valued at $2,449,000 after purchasing an additional 90,091 shares during the last quarter. Barclays PLC grew its holdings in shares of Avanos Medical by 446.2% during the 3rd quarter. Barclays PLC now owns 96,194 shares of the company's stock valued at $2,311,000 after purchasing an additional 78,583 shares during the last quarter. Rice Hall James & Associates LLC purchased a new stake in Avanos Medical during the 4th quarter valued at $989,000. Finally, FMR LLC boosted its position in Avanos Medical by 34.6% during the 3rd quarter. FMR LLC now owns 133,844 shares of the company's stock valued at $3,216,000 after buying an additional 34,421 shares during the period. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

Avanos Medical Stock Performance

AVNS traded down $0.15 during midday trading on Wednesday, reaching $17.24. The company had a trading volume of 131,664 shares, compared to its average volume of 638,668. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The stock has a market cap of $792.53 million, a PE ratio of 50.68 and a beta of 0.98. Avanos Medical has a 12-month low of $14.98 and a 12-month high of $25.36. The business has a 50-day moving average price of $16.87 and a two-hundred day moving average price of $20.45.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Avanos Medical from a "strong-buy" rating to a "buy" rating in a report on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.